Physician profile
Erin E Armstrong
NPI 1679573943
$15,242.89
in general payments reported to CMS, 2019-2025
36 companies · $3,220 in 2025
The $3,220 reported for 2025 was more than what 97% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,873 · 2022: $3,015 · 2023: $3,475 · 2024: $3,659 · 2025: $3,220.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K · Education: $157.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,197.02 |
| Education | $157.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,863.02 | 2021-2025 | |
| Incyte Corporation | $1,564.77 | 2021-2025 | Opzelura |
| Dermavant Sciences, INC. | $1,181.17 | 2022-2024 | Vtama |
| Sun Pharmaceutical Industries INC. | $1,167.27 | 2021-2025 | Blu-U, Absorica Ld, Winlevi |
| Novartis Pharmaceuticals Corporation | $944.27 | 2021-2025 | |
| Janssen Biotech, INC. | $912.91 | 2021-2025 | Tremfya, Simponi, Simponi Aria |
| Leo Pharma INC. | $850.23 | 2021-2025 | Adbry, Anzupgo |
| Pfizer INC. | $611.28 | 2021-2025 | |
| Ucb, INC. | $596.38 | 2021-2025 | Bimzelx, Cimzia |
| Arcutis Biotherapeutics, INC. | $532.82 | 2023-2025 | Zoryve |
| Genzyme Corporation | $439.10 | 2021-2025 | |
| Lilly USA, LLC | $368.80 | 2021-2025 | Ebglyss, Taltz, Olumiant |
| Paratek Pharmaceuticals, INC. | $365.99 | 2021-2024 | Nuzyra |
| E.R. Squibb & Sons, L.L.C. | $364.40 | 2022-2024 | Sotyktu |
| Regeneron Healthcare Solutions, INC. | $319.18 | 2021-2025 | Dupixent, Libtayo |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $308.17 | 2021-2025 | Nemluvio, Dysport, Aklief |
| Mayne Pharma Commercial LLC | $289.51 | 2022-2025 | |
| Amgen INC. | $244.37 | 2021-2025 | Otezla, Otezla |
| Organogenesis INC. | $241.42 | 2022-2023 | Puraply |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $210.93 | 2021-2024 | Cabtreo, Arazlo |
| Almirall LLC | $180.28 | 2021-2025 | Seysara, Klisyri |
| Ani Pharmaceuticals, INC. | $141.33 | 2022-2023 | Apexicon E |
| Sanofi-Aventis U.S. LLC | $79.99 | 2025 | |
| Vyne Pharmaceuticals INC. | $73.02 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $62.10 | 2022-2024 | Spevigo |
| Mallinckrodt Hospital Products INC. | $56.40 | 2025 | Acthar |
| Botanix Sb INC | $54.02 | 2025 | Sofdra |
| Journey Medical Corporation | $41.00 | 2022-2025 | |
| Janssen Scientific Affairs, LLC | $32.47 | 2022 | |
| Epi Health, LLC | $24.63 | 2022 | |
| Helsinn Therapeutics (U.S.), INC. | $24.34 | 2022 | |
| Dermira, INC. | $23.18 | 2021 | |
| Convatec INC. | $19.87 | 2025 | |
| Kerecis Limited | $19.33 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Organon LLC | $18.59 | 2025 | Vtama |
| Fresenius Kabi USA, LLC | $16.35 | 2023 | Idacio |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Armstrong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.